Home General Biotechnology Drug Patent Expirations in May 2012

Drug Patent Expirations in May 2012

Drug Patent Expirations in May 2012

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent NumberPatent Expiration
LIDODERMTeikoku Pharma Usalidocaine5,601,838May 2, 2012
LIDODERMTeikoku Pharma Usalidocaine5,411,738May 2, 2012
TRAVATAN ZAlcon Pharms Ltdtravoprost6,503,497May 6, 2012
TRAVATAN ZAlcon Pharms Ltdtravoprost6,849,253May 6, 2012
CRIXIVANMerck Sharp Dohmeindinavir sulfate5,413,999May 9, 2012
ALLEGRASanofi Aventis Usfexofenadine hydrochloride6,399,632May 11, 2012
CHILDREN’S ALLEGRA ALLERGYSanofi Aventis Usfexofenadine hydrochloride6,399,632May 11, 2012
CHILDREN’S ALLEGRA HIVESSanofi Aventis Usfexofenadine hydrochloride6,399,632May 11, 2012
ALLEGRASanofi Aventis Usfexofenadine hydrochloride6,187,791May 11, 2012
CHILDREN’S ALLEGRA ALLERGYSanofi Aventis Usfexofenadine hydrochloride6,187,791May 11, 2012
CHILDREN’S ALLEGRA HIVESSanofi Aventis Usfexofenadine hydrochloride6,187,791May 11, 2012
AGGRASTATMedicuretirofiban hydrochloride5,292,756May 14, 2012
COMBIVIRViiv Hlthcarelamivudine; zidovudine5,859,021May 15, 2012
PLAVIXSanofi Aventis Usclopidogrel bisulfate4,847,265*PEDMay 17, 2012
ACTONEL WITH CALCIUM (COPACKAGED)Warner Chilcottcalcium carbonate; risedronate sodium6,096,342*PEDMay 21, 2012
IMODIUM MULTI-SYMPTOM RELIEFMcneilloperamide hydrochloride; simethicone5,716,641May 21, 2012
VIRAMUNEBoehringer Ingelheimnevirapine5,366,972*PEDMay 22, 2012
ACTONELWarner Chilcottrisedronate sodium6,096,342*PEDMay 22, 2012
VIRAMUNE XRBoehringer Ingelheimnevirapine5,366,972*PEDMay 22, 2012
Subscribers have access to valuable datasets, including:
  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • Moreā€¦
See the Database Preview and Plan Comparison. Contact Us with any questions.

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com

NO COMMENTS

Leave a Reply